Please use this identifier to cite or link to this item:
Title: An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology
Authors: Cervia, Davide
Bagnoli, Paola
Keywords: Endogenous receptor;G protein;Transduction pathway;Somatotropinoma;Nervous system disease
Issue Date: 2007
Publisher: Elsevier
Source: Cervia, D., Bagnoli, P. 2007. An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology. "Pharmacology & Therapeutics" 116(2): 322-341
The peptide somatostatin (SRIF) has important physiological effects (mostly inhibitory) which have formed the basis for the clinical use of SRIF compounds. SRIF binding to its five G-protein coupled receptors leads to the modulation of multiple transduction pathways. However, our current understanding of signalling exerted by receptors endogenously expressed in different cells/tissues reflects a rather complicated picture. On the other hand, the complexity of SRIF receptor signalling in pathologies, including pituitary and nervous system diseases, may be studied not only as alternative intervention points for the modulation of SRIF function but also to exploit new chemical space for drug-like molecules.
L'articolo è disponibile sul sito dell'editore
ISSN: 0163-7258
DOI: 10.1016/j.pharmthera.2007.06.010
Appears in Collections:DISA - Archivio della produzione scientifica

Files in This Item:
File Description SizeFormat
Cervia & Bagnoli Pharm Ther 2007 1.pdf92.39 kBAdobe PDFView/Open
Show full item record

Page view(s)

Last Week
Last month
checked on Oct 29, 2020


checked on Oct 29, 2020

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.